A bill to permit the introduction or delivery for introduction of laetrile into interstate commerce without the approval of a new drug application under the Federal Food, Drug, and Cosmetic Act.

Amends the Federal Food, Drug, and Cosmetic Act to permit the introduction, or delivery for introduction, of laetrile (amygdalin) into interstate commerce without the approval of a new drug application.